Menard Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,019
Closed -$253K 159
2021
Q3
$253K Sell
2,019
-26
-1% -$3.37K 0.22% 133
2021
Q2
$254K Buy
2,045
+284
+16% +$35.7K 0.24% 127
2021
Q1
$208K Buy
+1,761
New +$206K 0.22% 134
2020
Q4
Sell
-3,832
Closed -$398K 150
2020
Q3
$398K Buy
3,832
+150
+4% +$15.1K 0.46% 54
2020
Q2
$337K Buy
+3,682
New +$353K 0.42% 58
2020
Q1
Sell
-5,096
Closed -$578K 82
2019
Q4
$578K Buy
+5,096
New +$559K 0.56% 60

Other funds holding MDT

Menard Financial Group's MDT Position: Q4 2021 in Review

Menard Financial Group sold out of Medtronic (MDT) in Q4 2021, closing a stake of 2,019 shares — an estimated $253K sold.

Menard Financial Group first reported a position in MDT in Q4 2019 and held it in 6 quarters. The position peaked at $578K in Q4 2019. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Menard Financial Group reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Menard Financial Group sold 2,019 Medtronic shares in Q4 2021, an estimated $253K.
  • Menard Financial Group first reported a position in Medtronic in Q4 2019 and held it in 6 quarters.
  • Menard Financial Group's Medtronic position peaked at $578K in Q4 2019.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Menard Financial Group's 13F filing for Q4 2021, filed 14 Feb 2022.